pharmabiotechpatentlitigation.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html User-agent: * Crawl-delay: 10 # CSS, JS, Images Allow: /misc/*.css$ Allow: /misc/*.css? Allow: /misc/*.js$ Allow: /misc/*.js? Allow: /misc/*.gif Allow: /misc/*.jpg Allow: /misc/*.jpeg Allow: /misc/*.png Allow: /modules/*.css$ Allow: /modules/*.css? Allow: /modules/*.js$ Allow: /modules/*.js? Allow: /modules/*.gif Allow: /modules/*.jpg Allow: /modules/*.jpeg Allow: /modules/*.png Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ Allow: /profiles/*.js?
Meta Tags
Title The Pharma & Biotech Patent Litigation Summit, Europe
Description Workshop The European Summit on Pharma and Biotech Patent Litigation will be back in January 2023 for 3 days of practical discussion around the leading industry topics. Our internationally recognised summit will provide you with the necessary practical tools
Keywords N/A
Server Information
WebSite pharmabiotechpatentlitigation faviconpharmabiotechpatentlitigation.com
Host IP 104.21.13.163
Location United States
Related Websites
Site Rank
More to Explore
pharmabiotechpatentlitigation.com Valuation
US$650,336
Last updated: 2023-05-18 06:57:23

pharmabiotechpatentlitigation.com has Semrush global rank of 16,275,148. pharmabiotechpatentlitigation.com has an estimated worth of US$ 650,336, based on its estimated Ads revenue. pharmabiotechpatentlitigation.com receives approximately 75,039 unique visitors each day. Its web server is located in United States, with IP address 104.21.13.163. According to SiteAdvisor, pharmabiotechpatentlitigation.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$650,336
Daily Ads Revenue US$601
Monthly Ads Revenue US$18,010
Yearly Ads Revenue US$216,112
Daily Unique Visitors 5,003
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
pharmabiotechpatentlitigation.com. 300 IN A A IP: 104.21.13.163
pharmabiotechpatentlitigation.com. 300 IN A A IP: 172.67.156.202
pharmabiotechpatentlitigation.com. 300 IN AAAA AAAA IPV6: 2606:4700:3033::ac43:9cca
pharmabiotechpatentlitigation.com. 300 IN AAAA AAAA IPV6: 2606:4700:3030::6815:da3
pharmabiotechpatentlitigation.com. 86400 IN NS NS NS Record: norm.ns.cloudflare.com.
pharmabiotechpatentlitigation.com. 86400 IN NS NS NS Record: lola.ns.cloudflare.com.
pharmabiotechpatentlitigation.com. 300 IN MX MX MX Record: 5 _dc-mx.2d3bd8beb59f.pharmabiotechpatentlitigation.com.
HtmlToTextCheckTime:2023-05-18 06:57:23
Toggle navigation REGISTER YOUR INTEREST UPC PRE DAY WHY ATTEND 2024 PARTNERS VENUE CONTACT US View All Partners Reviewing First UPC Decisions and their Impact on In-House Patent Litigation Strategy, Join Europe’s Leading Pharmaceutical and Biotech Legal Community to Define, Shape and Create Successful Patent Strategies and Mitigate Risks Register Your Interest Anantara Grand Hotel, Amsterdam 22-24 January, 2024 Register Your Interest View the full video “With an ever-changing IP landscape and the imminent arrival of the UPC, now is the time to join the Pharma and Biotech Patent Litigation summit.” Fred Grumitt, Event Director --> RETURNING FOR 2024 The European Summit on Pharma and Biotech Patent Litigation will be back in January 2024 for 3 days of practical discussion around the leading industry topics. Our internationally recognised summit will provide you with the necessary practical tools to both defend patent litigation challenges for your pharma and biotech product, whilst
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 26 May 2022 20:55:09 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Thu, 26 May 2022 21:55:09 GMT
Location: https://pharmabiotechpatentlitigation.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=5YDfAtoUcutLzPuzP3zQtKXSmoOevKZmjwl2xprDyLTnBOYIwtBMIDjWgXjjzUpHluv8Ekj5GOFXBZY8F%2F9vjmyHrRrY7hGfDNSl4jcVNXKYJ3khyhM7pYbHx7ZtDCfrMphiddeo8CNt67TY4KyX4YD5sQy50veSxwQ%2BjjpzzbY%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 711968fc2fb09b80-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

HTTP/2 301 
date: Thu, 26 May 2022 20:55:09 GMT
content-type: text/html
location: https://pharmabiotechpatentlitigation.com/events/patent-litigation-summit
x-eventsite: patent-litigation-summit
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=IPHsoYR1jm3009WDepx9wFmyK2GLIXfUXTrT1qgXkdzzJXZXaBuIzXs0YX%2FqVdWQhTYnYSvXJH0atoS%2BQwfpwrDD%2BaqXkbq1r5aggD5l62j7142hMb06w3iVhtMsFuASwqWp9VP3spPdmbymQUqGrNgN%2FxVJi4W5EdiJVr%2Fwx9w%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 711968fcb8d85c50-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

HTTP/2 200 
date: Thu, 26 May 2022 20:55:11 GMT
content-type: text/html; charset=utf-8
expires: Sun, 19 Nov 1978 05:00:00 GMT
cache-control: no-cache, must-revalidate
x-content-type-options: nosniff
content-language: en
x-frame-options: SAMEORIGIN
permissions-policy: interest-cohort=()
x-generator: Drupal 7 (http://drupal.org)
link: ; rel="canonical",; rel="shortlink"
vary: Accept-Encoding
x-eventsite: patent-litigation-summit
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=qcAhdeWBWsXqGFL0RzIkIwiRtirihqn3TpwXwaaMC9swfvw0wWEyADUQVjmgfZcr2BjQY%2Ftgim6LKmynF4JYcsIs8QV9lit9%2Fgoe%2BHAoGipBrFlxjyMmam%2BNv0ZL22eNeezZWyuHSOWcOoY1J%2B5bNIB3dK2kM7kKSD8eYIoSm4k%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 711968ff7f805c50-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
pharmabiotechpatentlitigation.com Whois Information
Domain Name: PHARMABIOTECHPATENTLITIGATION.COM
Registry Domain ID: 2625479159_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ascio.com
Registrar URL: http://www.ascio.com
Updated Date: 2021-08-26T15:37:12Z
Creation Date: 2021-07-09T15:58:08Z
Registry Expiry Date: 2023-07-09T15:58:08Z
Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Registrar IANA ID: 106
Registrar Abuse Contact Email: abuse@ascio.com
Registrar Abuse Contact Phone: +1.4165350123
Domain Status: ok https://icann.org/epp#ok
Name Server: LOLA.NS.CLOUDFLARE.COM
Name Server: NORM.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-26T22:15:10Z <<<